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Abstract
Background: The objective of this work was to study the vitamins B1,B 2,B 6 and C stability in a pediatric
formulation containing high amounts of calcium in the presence of organic phosphate, amino acids, glucose,
sodium chloride, magnesium sulfate, pediatric vitamins and trace elements under different conditions using
developed and validated analytical methods.
Methods: The study was carried out during 72 h with formulations packaged in recommended storage
temperature (4°C) and 25°C, with and without photoprotection.
Results: The results showed that the methodologies used for assessing the chemical stability of vitamins B1,B 2,B 6
and C in the formulation were selective, linear, precise and accurate. The vitamins could be considered stable in
the formulation during the three days of study if stored at 4°C. When stored at 25°C vitamin C presented instability
after 48 h.
Conclusion: The pediatric formulation containing high amount of calcium in the presence of organic phosphate,
amino acids, glucose, sodium chloride, magnesium sulphate, pediatric vitamins and trace elements packaged in
bag-type trilaminate presented a shelf life of the 72 h, when maintained under refrigeration, between 2°C and 8°C.
This shelf life was measured considering the vitamins studied. Further studies are needed including all the vitamins
present in this formulation.
Background
Vitamins are components of parenteral nutrition (PN)
used for attending the daily requirements and supplying
deficiencies in neonates and, in their majority, are
instable [1-3]. The chemical degradation is the most
usual cause of vitamin loss in the PN bag. Two reactions
are described as the most common and important: oxi-
dation of the ascorbic acid and the reduction of thia-
mine [4].
The ascorbic acid is the less stable vitamin added to
the PN, being rapidly oxidized stimulated principally by
high temperatures and catalysed by oligoelements as
copper [5-8]. The first step of its degradation route,
when converted to dehydroascorbic acid, is reversible
and this compound also has biological activity [9].
Other stages of the route are irreversible and produce
compounds without biological activity [10]. The degra-
dation of the ascorbic acid is based directly on the
amount of oxygen present in the medium, becoming
relevant the packing material used [4-8,11-13]. Several
amino acids also interfere in the stability of ascorbic
acid not only due its cysteine (cooper ions chelating),
but also by reducing its potential, which would decrease
the effect of residual oxygen [5-8,14,15]. Another rele-
vant factor related to vitamin C is the oxalic acid forma-
tion as degradation final product that has toxic potential
and rapidly reacts with free calcium, inducing the preci-
pitation of calcium oxalate [16].
The main route of degradation of the thiamine is caused
by its reduction due to the presence of sodium
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any medium, provided the original work is properly cited.metabisulfite, the antioxidant used in the amino acid crys-
talline solutions [4,7,11,16-18], concentrations of 1 mmlo/
L, which are sufficient to promote degradation [6]. Ribofla-
vin is one of the vitamins that present more sensibility to
photodegradation [7,19]. It is irreversibly converted in
luminoflavin, luminochromo and compounds of less
importance in the presence of oxygen [3,4].
A PN formulation comprises large amounts of dis-
solved components with reactive properties leading to a
high potential of incompatibility and instability. The
physicochemical instabilities include: formation and pre-
cipitation of insoluble salts (i.e. calcium monohydrogen
phosphate), degradation or complexation that can alter
the bioavailability of the components [20]. These reac-
tions are time-dependant, dependant on the concentra-
tion of reactants, pH-value, temperature, light exposure,
the presence of catalytically active components and the
container material [20].
Although the vitamins stability study in the PN is funda-
mental due to its importance in the efficacy and clinical
security. The vitamins assay methods described in the lit-
erature are in majority for determination in biological
matrix as blood, serum and maternal milk, or in pharma-
ceutical forms [1-3,21]. The selective quantification of the
vitamins, in this complex matrix (PN) is an analytical chal-
lenge [9,22,23]. Ascorbic acid is the vitamin most studied
in PN due to its labiality. Methods for vitamin C quantifi-
cation are available in the literature by HPLC [8,11,12],
spectrophotometry [6] and titration [24]. They can also be
found in the literature method for analysis of vitamin B1
using HPLC [11,12,19], but the stability of vitamins B2 and
B6 are less studied and there is no validated method avail-
able for quantification of these vitamins in PN. Despite the
availability of some methods in the literature there are not
official methods for analysis of vitamins in PN, as pharma-
copeia. The establishment of an official method is ham-
pered by the heterogeneity of the PN prescribed. Thus, the
reliability of a method for analysing a compound in differ-
ent formulations should be evaluated by the validation.
Thus, in this work we developed and validated analytical
methods for selectively assay of vitamins B1,B 2,B 6 and C
in the PN formulation studied.
The objective of this study was to quantify vitamins
B1,B 2,B 6 and C in PN formulations in order to investi-
gate the degradation of these vitamins in a pediatric PN
containing a high concentration of calcium (93 mg/100
mL) in the presence of organic phosphate (1.1 mEq/100
mL), oligoelements and amino acids, packaged in the
trilaminate bag under different conditions.
Methods
Formulation preparation
The formulation studied was composed by: 3 g of Pedia-
mino TAU amino acid (Baxter; São Paulo; Brazil), 8,64 g
of glucose 50% (Fresenius; Campinas; Brazil), 4 mEq
sodium chloride 20% (Darrow; Rio de Janeiro; Brazil),
4,5 mEq calcium gluconate 10% (Halex Istar; Goiânia;
Brazil), 1.1 mmoL sodium glycerophosfate 21.6% (Frese-
nius), 0.25 mEq magnesium sulfate 0.8%, 0.1 mL Ped
element (Darrow) and 10 mL MVI 12 opoplex for adult
(ICN Farmacêutica; São Paulo; Brazil). The vitamins
concentration in PN: 2 mg/mL of vitamin C, 8 μg/mL
of folic acid, 1.2 μg/mL of biotin, 0,01 μg/mL of ciano-
cobalamin, 0.03 mg/mL of pantotenic acid, 0.072 mg/
mL of B2, 0,8 mg/mL of nicotinamin, 0.08 mg/mL of B6,
0.06 mg/mL of B1,0 . 0 3 6 4m g / m Lo fv i t a m i nA ,0 . 1μg/
mL of vitamin D, 0.2 mg/mL of vitamin E. The final
volume of 100 mL was completed with water for injec-
tion and packaged in a trilaminate bag with capacity of
300 mL (Halex Istar).
Reagents and chemical substance of reference
The reagents hydrogen peroxide PA, hydrochloric acid,
sodium 1-hexanesulfonate, methanol and glacial acetic
acid spectrophotometric grad were purchased from
Merck (Darmstadt, Germany). The chemical substance
of reference of thiamine hydrochloride (purity: 99.0%)
and pyridoxine hydrochloride (purity: 99.9%) were pur-
chased from Roche (Basel, Switzerland). The chemical
substance of reference of ascorbic acid (purity: 99.0%)
was purchased from Spectrum Chemical (New Bruns-
wick, USA) and the riboflavin 5-fosfate sodium dehy-
drated (purity: 99.2%) from Merck. Other reagents were
obtained from local suppliers.
Formulation preparation
T h eP Na d m i x t u r ef o r m u l a sf o rn e o n a t a lu s ew e r ep r e -
pared aseptically in a 300-mL 3-layered bag composed
by polyester, polypropylene and polyethylene (HalexIs-
tar, Goiânia, Brazil) under a laminar-flow hood in accor-
dance with the National Health Department
specifications Nr. 272 (1988), designed for infusion
through central access. The PN admixture formulas
were prepared with market products from pharmaceuti-
cal industries and based on official regulations [25-29].
The choice of composition was based in the literature
recommendations of preterms [26]. For micronutrients,
today, there are controversies regarding the optimal
dose of vitamins for preterms. A standard supplementa-
tion is often not enough to compensate this patient. It is
necessary to use pharmacological doses that exceed the
recommendations of the literature [30]. Because of this
evidence, the concentrations of the vitamins were
overestimated.
Each admixture was prepared separately in triplicate
or quadruplicate (referred to as 3 or 4 lots) divided into
two at different temperatures: 4°C ± 2°C, in refrigerator;
and in 25°C ± 3°C, simulating room temperature. A
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the lots depending on the technique applied. The
experiments were performed on the day of the admix-
tures preparation and also 24 h, 48 h, and 72 h after
preparation, time periods indicated as D0, D1, D2 and
D3 respectively.
Samples were aseptically collected from each formula-
tion at appropriate intervals using a plastic syringe for
the physicochemical tests.
pH evaluation
For the evaluation of pH, a Mettler Toledo potenti-
ometer calibrated with pH 4 and pH 7 buffers was used.
For each measurement, a 10 mL sample was collected
and placed in an amber glass flask. The pH was mea-
sured by dipping the electrode directly into the solution,
at room temperature. The pH determination was carried
out each day in quadruplicate for each formulation in
all the conditions studied.
Development of analytical methodologies
The initial analytical conditions for the development of
the chromatographic method for vitamins B1 and B6
w e r eb a s e di nm e t h o d sd e s c r i b e di nt h el i t e r a t u r ef o r
other purposes [1,2,21,23]. The wavelength of maximal
absorption for each vitamin was determined using indi-
vidual standard solutions of vitamins B1 and B6 (8 μg/
mL) for obtaining an absorption spectrum in the UV
region. Later, the retention time of each vitamin in the
chromatographic system was determined. For the rou-
tine analysis, a single standard solution containing the
B1 and B6 was prepared, using the mobile phase as dilu-
ent. The HPLC analysis was realized using diode array
detection, by the area under the peak in the wavelength
of maximal absorption, 250 and 295 nm for B1 and B6,
respectively. For the mobile phase selection, different
proportions of methanol: water were tested, 50:50,
40:50, 27:73, 25:75 and 20:80 (v/v). The mobile phase
was kept at pH 3.0 using glacial acetic acid. A Shimadzu
HPLC system was used equipped with a SPD-
M10APDA detector. Data was acquired with Class-VP
6.1 software. The ideal chromatographic conditions
obtained for the assay of the vitamins was Bondapack
C18 column size 300 mm × 13 mm, 10 μm( W a t e r s ,
Milford, USA); mobile phase consisting of a mixture of
methanol: water (27:73; v/v) and 1.4% of sodium 1-hexa-
nesulfonate for the ionic par formation; flux rate of 0.35
mL/min with detection at 250 and 295 nm and 30 μLo f
injection volume.
The fluorescence is a common phenomenon in aro-
matic molecules, as vitamin B2 [31]. Based in the
method applied to the raw material vitamin B2 of the
USP a selective and sensitive method to assay B2 in the
PN [28] was developed. Initially, a preliminary study was
realized to set the emission and excitation wavelength to
detect the vitamin B2 i nt h eP N .T h ee m i s s i o nr a n g e
was between 400-700 nm, with intervals of 5.0 nm; with
excitation at 360 nm, with 2.5 nm of interval; and scan
velocity of 1000 nm/min in a Jasco fluorimeter.
Based on the reduction potential of vitamin C, the
iodometric titration was applied to assay this vitamin in
the PN based in the pharmacopeical methodology for
raw material and tablets [23]. The titrant used was
iodine 0.05 M SV. The sample was diluted in sulfuric
acid 10% (w/v; 25 mL) and a solution of starch 1% (3
mL) and distilled water in sufficient quantity for com-
pleting 100 mL were used as indicators. The end point
was determined by the formation of a blue coloration.
Each mL of iodine 0.05 M VS (volumetric solution) cor-
responds to 8.806 mg of ascorbic acid [24].
Validation of analysis methodologies for assaying
vitamins B1,B 2,B 6 and C in the PN
The methodologies used for the assay of vitamins B1,B 2,
B6 and C in the PN were validated by the selectivity of
the vitamins and their degradation products in the for-
mulation, linearity, precision and accuracy in accordance
with recommended procedures [8,32,33].
The specificity of the method for assay of the B1 and
B6 in the presence of other formulation components of
the PN was evaluated by the comparison of the chroma-
tograms obtained from a PN containing the standard
vitamins in study (B1 and B6) with PN without the vita-
mins (placebo). The purity determination of the chro-
matographic peaks was also used with the software of
diode array detector. The specificity of the assay of vita-
min B2 was determined by the comparison between the
spectrum of PN with the standard B2, placebo and the
PN, verifying that the peak observed in the spectrum is
attributed to one component alone. For the vitamin C
the titration of the placebo was carried out. The results
obtained in the placebo were discounted later from the
volume obtained with the PN containing the vitamin C.
The linearity was evaluated in three different days, by
three vitamins standard with five concentration levels, in
the ranges of 20-60 and 30-90 μg/mL (B1 and B6,
respectively), 1-5 μg/mL (B2) and 50-150 mg (C). The
linearity of the method was determined by linear regres-
sion analysis of the values obtained experimentally with
the software Excel
® (Microsoft, 2002).
The precision of the injection was evaluated in five
concentration levels of vitamins B1 and B6: 20-60 μg/mL
and 30-90 μg/mL, respectively, in three runs each. The
standard deviation (SD) and the relative standard devia-
tion (RSD) were calculated for each point, from the
obtained area.
Precision was considered at two levels: repeatability
and intermediate precision. It was determined by intra
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were prepared and aliquots were taken to prepare solu-
tions at three levels of concentration: 80%, 100% and
120% of the sample work concentration. For B1 (30, 40
and 50 μg/mL); B6 (45, 60 and 75 μg/mL); B2 (3, 3.5
and 4.5 μg/mL); and C (80, 100 and 130 mg). The preci-
sion of the method was assessed by the SD and RSD of
the values obtained experimentally in three days conse-
cutively. The accuracy of the method was verified by
determining the known recovery amount of standard
vitamins in the spiked PN placebo.
Stress stability study of vitamins B1,B 6, and B2 in the PN
In order to test the selectivity of the developed meth-
odologies for assaying the vitamins studied in PN in the
presence of possible degradation products, an acceler-
ated degradation of vitamins, under forced conditions
[32] was performed. The assay was carried out sepa-
rately for each vitamin using the respective analytical
method developed. For this, standard solutions were
prepared, one with 40 μg/mL of vitamin B1 and 60 μg/
mL of B6, and another with 3.5 μg/mL of B2. Each vita-
min standard solution was stressed using 3% and 10% of
hydrogen peroxide for 24 h, at room temperature. After
0, 6 and 24 h of reaction the samples were withdrawn
and analysed using the respective methods.
Samples preparation
Samples from PN were withdrawn volumetrically to
carry out the vitamins assay. For B1 and B6 were used
aliquots of 7 mL and for B2 0.5 mL. Each sample was
transferred to a volumetric vessel of 10 mL and the
volume completed with mobile phase for B1 and B6 and
with PN without vitamins for the B2.
Vitamin C assay was carried out on a volumetric ali-
quot of 50 mL. The sample of PN was transferred to an
Erlenmeyer containing 25 mL of sulfuric acid 10%, 3
mL of starch solution 1% and distilled water in sufficient
quantity for 100 mL. This mixture was immediately
titrated with iodine volumetric solution 0.05 M.
Statistic Treatment
The experimental results obtained were presented as
mean and standard deviation (SD). Comparisons
between the results were evaluated by unpaired Stu-
dent’s t test with a 95% of confidence limit. Values of p
< 0.05 were considered statistically significantly.
Results and Discussion
Development and validation of analytical methods
The HPLC method was developed by assaying vitamins
B1 and B6 in the same run. The selectivity of vitamins
B1 and B6 assay was determined by comparing the chro-
matograms obtained from placebo, spiked PN with
standard vitamins and samples of PN (Figure 1). The
chromatograms show that despite the peaks presence of
the other components, the vitamins B1 and B6 peaks
were satisfactory separated from those others. The peak
purity was of 0.9991 and 0.9999 for vitamin B1 and B6,
respectively. The peak purity was calculated using the
Shimadzu Class-VP 6.1 software.
The selectivity of the assay used for the determina-
tion of vitamin B2 in PN was confirmed by the com-
parison of fluorescence emission spectrums obtained
from placebo and PN samples with B2 in the usual
concentration (Figure 2). Three standard curves were
also prepared, with five levels each, in the concentra-
tion range of 1 to 5 μg/mL, using solution of B2 in
water, spiked placebo with B2 and PN sample. From
these curves could be observed the spectrophotometric
profile of the fluorescence light emission from vitamins
B2 and the adequate linearity and selectivity of the
method for this vitamin. This was evidenced due to
the similarity of the vitamins B2 in water and spiked
placebo with B2 curves, showing that with the estab-
lished parameters the others PN components did not
interfere in the assay. The curve obtained with the PN
sample was above the other curves, but parallel due to
the major concentration of vitamin B2 in this case. For
the iodometric titration assay applied for the vitamin C
in PN, the selectivity was evidenced by the low volume
of the titrant, approximately 0.5 mL, necessary for pla-
cebo titration, compared with the volume used for
Figure 1 Specificity of the vitamin B1 and B6 assay.
Chromatograms of PN placebo (A and D), spiked with the B1 and
B6 (B and E) and PN containing the multivitamin (C and F) obtained
by HPLC at wavelength of 250 and 295 nm, respectively, using
column of reverse phase C18 and a mixture of methanol:water
(27:73, v/v) and sodium hexano sulfonate 1,4%, pH 3.0 as mobile
phase (n = 3).
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between 5.0 and 16 mL.
The linearity relationship was evaluated across a
range of each analytical procedure by three standard
curves, realized in three different days, as presented in
Table 1. The regression lines proved the adequate line-
a r i t yo ft h em e t h o d s( T a b l e1 ) .T h ep r e c i s i o nw a s
determined by the RSD between the values obtained
with the spiked samples with standard vitamins. In
accordance with the Table 2, the precision of the
methods were demonstrated adequately, since none of
the values of RSD found for each level of concentra-
tion were less than 5% [28,33]. The system suitability
test for HPLC was defined based on the results
obtained in several chromatograms. The efficiency col-
umn determined by the analyte peak was >2000, the
tailing factor <1.5 and the system precision was evalu-
ated by six repeated assays o ft h es a m es o l u t i o n ,t h e
RSD was less than 2% [28].
T h er e c o v e r yd a t aw e r eo b t a i n e df r o mt h ea s s a yo f
the known amounts of standard vitamins spiked to the
placebo. The obtained values were in a range of 98.6
to100.8% for all the developed methods, as demon-
strated in Table 3. The mean values of the recovery
data achieved show that there was no interference of
the placebo and the accuracy of the methods was
demonstrated.
Stress degradation study on vitamins B1,B 6 and B2 in the
PN
In addition to testing the specificity of the methods by
the evaluation of PN with and without the standard vita-
mins, an accelerated study of the vitamins was carried
out. This procedure aimed to ensure that the degrada-
tion products were not being quantified simultaneously
with the studied vitamins. The stress degradation study
for vitamin C was not necessary as the method applied
is a pharmacopeical methodology.
In the panel A and B of Figure 3 the results of the
chemical accelerated stability study of the vitamins B1,
B6 and B2 after 6 h of oxidation using hydrogen perox-
ide 3% and 10% are demonstrated. The content remain-
ing using hydrogen peroxide 3% and 10%, respectively,
for B1 were: 74.7% and 59.8%; for B6: 98.4% and 92.4%;
for B2: 80.6% and 60.9%. The panel C shows the results
of the chemical accelerated stability study of the vita-
mins B1,B 6,B 2 after 24 h of oxidation using hydrogen
peroxide 10%. The remaining content of B1 was of
12.7%; for B6 88.9%; and for B2 36.7%.
The results obtained by the accelerated degradation
tests of the studied vitamins demonstrated the selectivity
of the methods developed in the presence of degrada-
tion products in PN.
Determination of the stability of vitamins B1,B 6,B 2 and C
in PN
The choice of composition was based in the literature
recommendations of preterms [26]. For micronutrients,
today, there are controversies regarding the optimal
dose of vitamins for preterms. A standard supplementa-
tion is often not enough to compensate this patient. It is
necessary to use pharmacological doses that exceed the
recommendations of the literature [30]. Due to this evi-
dence, the concentration of the vitamins was
overestimated.
Figure 4 shows the mean and the standard deviation
of the reminiscent B1 and B6 quantity in the formulation
until 72 h of storage. The residual quantities after stored
at 4°C for B1 and B6 were: 96.4% ± 3.1% and 97.5% ±
Figure 2 Specificity of the vitamin B2 assay.F l u o r e s c e n c e
emission spectra of PN without (A) and with the standard vitamins
B2 (B) with a range of emission wavelength between 400-700 nm
and excitation at 360 nm.
Table 1 Regression analysis results of data for assaying vitamins B1,B 6,B 2 and C by HPLC, fluorescence and
iodometric titration, respectively
Features Vitamins
B1 B6 B2 C
Range 20-60 μg/mL 30-90 μg/mL 1-5 μg/mL 50-150 mg
Regression equation
a Y = 214695 x + 3168877 Y = 191100 x - 130681 Y = 57.9 x + 28.3 Y = 0.1x + 2.36
SE of intercept 2140.2 694.4 4.5 4.05
SE of slope 48166.4 3445.3 1.9 0.0
Correlation coefficient (r
2) 0.9984 ± 1.45·10
-3 0.9989 ± 1.54·10
-3 0.9999 ± 0.00 0.9999 ± 5.0·10
-5
ay = bx + a, where x is the concentration in μg/mL, except for vitamin C in mg, y is the peak area, for HPLC method, the intensity for fluorescence and volume
for titration; a is the intercept and b is the slope. SE= standard error.
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93.1% ± 6.0%; without photoprotection: 95% ± 7.6% and
94% ± 5.0%, respectively. The residual B2 quantity after
72 h of storage at 4°C was: 99.4% ± 1.1%; at 25°C with
photoprotection: 94.7% ± 9.2%; and without photopro-
tection: 99.0% ± 1.6% (Figure 5). Statistically significative
variations had not been observed (p > 0.05) for the vita-
mins during the days of study and under the studied
temperatures.
The mean and the standard deviation of the remaining
vitamin C percentage within 72 h of storage are pre-
sented in the Figure 6. The residual contents after sto-
rage at 4°C were: 94.4% ± 2.9%; at 25°C with
photoprotection: 85.9% ± 1.1%; and without photopro-
tection: 87.8% ± 1.3%, showing statistically significant
chemical alteration (p < 0.05) of vitamins C in the tem-
perature of 25°C with and without photoprotection dur-
ing the study.
According to ICH, the shelf life of a formulation can
be estimated as the period time that the concentrations
of the components are not reduced more than 10%
[34]. No significant stability alteration (p > 0.05) was
observed in the study of vitamins B1,B 2 and B6 during
72 h in all studied conditions, i.e., less than 10% of
content loss, as demonstrated in the Figures 4 and 5.
However, the vitamin C presented significant alteration
(p < 0.05), around 15% of loss after 72 h, when stored
at 25°C independent of photoprotection, as demon-
strated in Figure 6. These results were expected,
because there was not incidence of direct natural light
in the PN studied, only indirect natural light or artifi-
cial light. The observed degradation of vitamin C in
the formulation could be due to other interfering fac-
tors such as the presence of oxygen, the storage tem-
perature and the presence of oligoelements. It is
important to reinforce that the important parameter
for the variation of the vitamin C loss was the storage
temperature, as observed in others studies [6,11] since
the PN with and without photoprotection, when kept
at 25°C, showed assay values very close and in the sto-
rage temperature indicated by the literature, between
2°C and 8°C, no significant alteration in the assay was
observed. The loss of vitamin C observed was similar
to other studies containing trace elements and vitamins
in PN stocked in trilaminar bag [5,7,8]. Moreover, the
relative stability of vitamin C is due to the bag used in
this study. The trilaminate bag is 100 times less perme-
able to the oxygen than the EVA material, so the oxi-
dation reaction occurs in minor intensity [23].
However, it has been reported the importance of
removing the residual oxygen inside the bag after its
preparation [6]. The mean and standard deviation of
pH values for PN admixtures during the three days of
study, at the two different temperatures selected were
measured. In all cases the pH remained around 5.5
throughout the study period and showed no significant
differences between the values of D3 and D0 in each
condition tested.
Table 2 Intermediate precision values obtained using the methods for vitamin B1,B 6,B 2 and C analyses in PN
80% 100% 120%
Day ID RSD (%) IT RSD (%) ID RSD (%) IT RSD (%) ID RSD (%) IT RSD (%)
B1 1 1.78 1.40 1.89 2.00 0.48 0.88
2 1.26 0.63 1.06
B6 1 0.63 0.90 1.68 1.55 0.41 1.96
2 1.01 0.95 0.98
B2 1 0.40 1.18 1.09 1.59 1.08 1.61
2 1.17 0.67 0.90
C 1 0.71 1.46 0.57 1.33 0.43 0.56
2 0.69 0.55 0.43
ID RSD means intraday relative standard deviation and IT RSD interday relative standard deviation of 3 measurements average in each day. n = 2 lots.
Table 3 Experimental values obtained in the recovery test of vitamin B1,B 6,B 2 and C by HPLC, fluorescence and
titration, respectively
[B1]( μg/
mL)
Mass found (%) ±
RSD
[B6]( μg/
mL)
Mass found (%) ±
RSD
[B2]( μg/
mL)
Mass found ± RSD
(%)
[C]
(mg)
Mass found (%) ±
RSD
20 98.6 ± 3.05 30 99.2 ± 1.26 2 98.7 ± 1.35 50 98.7 ± 0.81
30 100.7 ± 2.21 45 100.6 ± 1.97 3 100.7 ± 1.22 80 99.2 ± 1.42
40 98.2 ± 3.82 60 99.8 ± 2.45 3 100.8 ± 1.13 100 98.9 ± 1.19
50 100.2 ± 0.90 75 99.8 ± 1.13 4 100.0 ± 1.27 130 100.0 ± 1.01
60 99.6 ± 0.69 90 99.9 ± 0.58 5 99.6 ± 0.89 150 99.5 ± 0.89
* Each value represents the mean of 3 analyses.
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of reduction agents for vitamin B1 are factors that con-
tribute to the loss of stability [16]. In the pH range
between 5 and 6, the amino acids composition and
reduction agents studied did not show significant altera-
tion in the content of this vitamin (p > 0.05). It is
described in the literature that concentrations of 1
mmol/L of sodium metabisulfite is sufficient to cause
degradation of this vitamin and that when this reducing
agent is diluted, it does not interfere in this degradation.
This fact could be proven, since the PN studied, con-
tained 0.078 mmol/L of sodium metabisulfite, below the
quantity described as safe.
The presence of high concentration of calcium asso-
ciated with organic phosphorus in the presence of oli-
goelements did not affect the stability of the analyzed
Figure 3 Stress study of vitamins B1,B 2,a n dB 6 in PN.
Percentage remaining of vitamins after 6 h of oxidation using
hydrogen peroxide 3% (A) and 10% (B) and after 24 h using
hydrogen peroxide 10% (C).
Figure 4 Stability study of vitamin B1 and B6. Residual content
of B1 (A) and B6 (B) in PN stored at storage temperatures of 4°C
and 25°C with and without photoprotection (n = 3 lots; P > 0.05,
D3 compared with D0).
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at 25°C, in which there was a loss of 15% in 72 hours of
study. This formulation was chosen due its similarity to
in uterus conditions, which favours greater bone miner-
alization [35], but with potential risk due to the low
final volume and possible interactions leading to loss of
vitamins, that, in this formulation was overestimated
[4,36-38]. Some works have suggested a possible chemi-
cal instability due interaction between vitamins and oli-
goelements mixed in the same bag. A previous study
demonstrated the compatibility and physicochemical
stability of this formulation, but the stability of the vita-
mins in this formulation remained to be investigated at
that time [38]. The lipid emulsion (LE) has a role of
photoprotector in the PN, thus its absence favours the
degradation of photo sensible vitamins as B2 and C
[7,8,13,16]. So, possibly, the stability of these vitamins
will be increased in formulations containing LE.
In spite of PN being an extemporaneous product,
knowing the stability characteristics of this formulation
makes possible to establish a quarantine period in order
t or e a l i z ee f f e c t i v em i c r o b i ological control to promote
major security in its administration. However, in order
to obtain a complete outlook of the chemical stability of
the vitamins in this formulation, further studies are
needed including all the vitamins present in this formu-
lation, since the PN contains vitamins beyond those stu-
died here.
Conclusions
The results obtained show that the methodologies used
for assessing the chemical stability of vitamins B1,B 2,B 6
and C in the formulation were selective, linear, precise
and accurate. The vitamins B1, B2 and B6 added in a
PN containing high concentration of calcium associated
with organic phosphorus in the presence of oligoele-
ments could be considered stable during the three days
of study, when stored between 4°C and 25°C. The vita-
min C presented stability for 48 h at 25°C, with or with-
out photoprotection. Considering the vitamins studied,
the shelf life of the formulation studied is 72 h, if main-
tained under refrigeration, between 2°C and 8°C. Further
studies are needed including all the vitamins present in
this formulation.
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